Yasushi Kawasaki Selected Research

Yasushi Kawasaki Research Topics

Disease

4	Neoplasms (Cancer) 01/2018 - 08/2003
3	Acute Lung Injury 01/2022 - 10/2011
3	Leukemia 12/2006 - 11/2002
2	Nephrosis 01/2023 - 01/2019
2	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2022 - 01/2014
2	Lung Injury 01/2022 - 01/2014
2	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2014 - 10/2011
2	Body Weight (Weight, Body) 08/2009 - 01/2003
2	Hematologic Neoplasms (Hematological Malignancy) 08/2009 - 12/2006
1	Nephrotic Syndrome (Syndrome, Nephrotic) 01/2023
1	Chronic Renal Insufficiency 01/2023
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Inflammation (Inflammations) 01/2023
1	Heart Diseases (Heart Disease) 01/2019
1	Atrial Fibrillation 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019
1	Stable Angina 01/2019
1	Hypoxia (Hypoxemia) 03/2018
1	Adenocarcinoma of Lung 03/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2018
1	Kidney Neoplasms (Kidney Cancer) 01/2018
1	Sepsis (Septicemia) 01/2014
1	Esophageal Neoplasms (Esophageal Cancer) 01/2014
1	Infections 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2009
1	Myeloid Leukemia (Leukemia, Myelocytic) 08/2009
1	High Pressure Neurological Syndrome (High Pressure Nervous Syndrome) 08/2009
1	Hepatocellular Carcinoma (Hepatoma) 07/2008
1	Lymphoma (Lymphomas) 12/2006
1	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2004

Drug/Important Bio-Agent (IBA)

5	Benzene (Benzole)IBA 08/2009 - 11/2002
3	Proteins (Proteins, Gene)FDA Link 01/2023 - 03/2018
3	LipidsIBA 01/2023 - 10/2014
2	Secretory Proteinase Inhibitory ProteinsIBA 01/2014 - 10/2011
2	sivelestatIBA 01/2014 - 10/2011
1	Liver X ReceptorsIBA 01/2023
1	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2023
1	AntibodiesIBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptor-3 (Flt 4)IBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	LipopolysaccharidesIBA 01/2022
1	Vascular Endothelial Growth Factor CIBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Hyperpolarization-Activated Cyclic Nucleotide-Gated ChannelsIBA 01/2019
1	IvabradineIBA 01/2019
1	Endoplasmic Reticulum Chaperone BiPIBA 03/2018
1	TransferasesIBA 03/2018
1	ThapsigarginIBA 03/2018
1	Isoaspartic Acid (Isoaspartate)IBA 03/2018
1	Protein D-Aspartate-L-Isoaspartate Methyltransferase (Protein L Isoaspartate D Aspartate O Methyltransferase)IBA 03/2018
1	D-Aspartic Acid (D Aspartate)IBA 03/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Claudin-1IBA 01/2018
1	Cadherins (E-Cadherin)IBA 01/2018
1	Membrane Proteins (Integral Membrane Proteins)IBA 01/2018
1	Peptide Hydrolases (Proteases)FDA Link 01/2018
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2018
1	aralinIBA 10/2014
1	SaporinsIBA 10/2014
1	Oxygen (Dioxygen)IBA 01/2014
1	Drinking WaterIBA 08/2009
1	14-3-3 Proteins (14-3-3 Protein)IBA 07/2008
1	Protein Isoforms (Isoforms)IBA 07/2008
1	ThioredoxinsIBA 12/2006
1	Aryl Hydrocarbon Receptors (Aryl Hydrocarbon Receptor)IBA 12/2006
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2006
1	MucinsIBA 01/2004
1	Cytochrome P-450 CYP2E1 (CYP2E1)IBA 01/2004
1	Olive OilIBA 01/2003
1	bis(2,3,3,3-tetrachloropropyl) ether (S 421)IBA 01/2003

Therapy/Procedure

1	Artificial Respiration (Mechanical Ventilation) 01/2014
1	Critical Care (Surgical Intensive Care) 01/2014